BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1724390)

  • 1. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
    Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in normal rats.
    Yoshino T; Tamura M; Hattori K; Kawamura A; Imai N; Ono M
    Int J Hematol; 1991 Dec; 54(6):455-62. PubMed ID: 1724389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.
    Stewart AG; Cotterill T; Harris T
    Immunology; 1994 May; 82(1):51-6. PubMed ID: 7519173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist.
    Rutella S; Rumi C; Testa U; Sica S; Teofili L; Martucci R; Peschle C; Leone G
    Bone Marrow Transplant; 1997 Sep; 20(5):355-64. PubMed ID: 9339749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
    Carulli G; Azzarà A; Minnucci S; Angiolini C; Sbrana S; Ambrogi F
    J Exp Clin Cancer Res; 1997 Sep; 16(3):301-8. PubMed ID: 9387905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
    Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte kinetics in neutrophilia induced by recombinant human granulocyte colony-stimulating factor in mice.
    Yamagiwa A
    Fukushima J Med Sci; 1991 Jun; 37(1):1-11. PubMed ID: 1725671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of recombinant human granulocyte colony-stimulating factor on white blood cell count and neutrophil functions in patients with malignant lymphoma].
    Ashida T; Ishikawa H; Urase F; Satoh M; Tsubaki K; Horiuchi A
    Rinsho Ketsueki; 1989 Oct; 30(10):1778-82. PubMed ID: 2480462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo effects on human neutrophils by administration of rhG-CSF and clinical significance].
    Okabe M; Saiki I; Nakane K; Miyazaki T
    Rinsho Byori; 1992 Apr; 40(4):397-402. PubMed ID: 1375667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor.
    Colgan SP; Gasper PW; Thrall MA; Boone TC; Blancquaert AM; Bruyninckx WJ
    Exp Hematol; 1992 Nov; 20(10):1229-34. PubMed ID: 1385198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.